EUCTR2009-017409-13-ES进行中（未招募）不适用
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemia
Sanquin Plasma Products0 个研究点开始时间: 2010年6月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Established diagnosis of atransferrinemia, defined as serum levels of transferrin below 40 mg/dl
- •2. Informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Known with allergic reactions against human plasma or plasma products
- •2. Having detectable anti-IgA antibodies
研究者
相似试验
进行中（未招募）
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaAtransferrinemiaMedDRA version: 20.0Level: LLTClassification code 10055212Term: Hypochromic microcytic anemiaSystem Organ Class: 100000004851MedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851MedDRA version: 21.0Level: PTClassification code 10065973Term: Iron overloadSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 21.0Level: PTClassification code 10005620Term: Blood iron increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: PTClassification code 10044356Term: Transferrin decreasedSystem Organ Class: 10022891 - InvestigationsEUCTR2009-017409-13-DEProthya Biosolutions Netherlands B.V.6
招募中
2 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemia2024-515986-33-00Prothya Biosolutions Netherlands B.V.5
招募中
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaCongenital atransferrinaemia/ hypotransferrinaemiaMedDRA version: 23.1Level: PTClassification code: 10084860Term: Hypotransferrinaemia Class: 100000004851MedDRA version: 23.0Level: LLTClassification code: 10083978Term: Congenital atransferrinaemia Class: 10010331MedDRA version: 20.0Level: PTClassification code: 10044356Term: Transferrin decreased Class: 100000004848MedDRA version: 21.0Level: PTClassification code: 10065973Term: Iron overload Class: 100000004861MedDRA version: 20.0Level: LLTClassification code: 10055212Term: Hypochromic microcytic anemia Class: 10005329MedDRA version: 21.0Level: PTClassification code: 10005620Term: Blood iron increased Class: 100000004848CTIS2024-515986-33-00Prothya Biosolutions Netherlands B.V.4
招募中
不适用
Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate to teeth extraction sockets for dental implant in Japanese participantsJPRN-UMIN000008795Kyushu University Hospital12
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-CZAbbott GmbH & Co. KG100